Microanalysis of β-lactam antibiotics and vancomycin in plasma for pharmacokinetic studies in neonates

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 1, 2009, Pages 75-80

  Ahsman, Maurice J ^a   Wildschut, Enno D ^b   Tibboel, Dick ^b   Mathot, Ron A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFOTAXIME; CEFTRIAXONE; DEACETYLCEFOTAXIME; MEROPENEM; VANCOMYCIN;

ANTIMICROBIAL THERAPY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG STABILITY; ELECTROSPRAY MASS SPECTROMETRY; EXTRACORPOREAL OXYGENATION; HUMAN; LIQUID CHROMATOGRAPHY; MICROANALYSIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEPSIS; TANDEM MASS SPECTROMETRY;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CEFAZOLIN; CEFOTAXIME; CEFTRIAXONE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; INFANT, NEWBORN; TANDEM MASS SPECTROMETRY; THIENAMYCINS; VANCOMYCIN;

EID: 59749088256     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00636-08     Document Type: Article

References (20)

1. Amaker, R. D., J. T. DiPiro, and J. Bhatia. 1996. Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation. Antimicrob. Agents Chemother. 40:1139-1142.
2. Anonymous. 2001. Guidance for industry - bioanalytical method validation. Biopharmaceutics Coordinating Committee, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, MD.
3. Basma, V. 2004. Stability and compatibility of vancomycin for administration by continuous infusion in intensive care patients. European Congress of Clinical Microbiology and Infectious Diseases, Prague, Czech Republic.
4. Careri, M., and A. Mangia. 2006. Validation and qualification: the fitness for purpose of mass spectrometry-based analytical methods and analytical systems. Anal. Bioanal. Chem. 386:38-45.
5. Chou, Y. W., Y. H. Yang, J. H. Chen, C. C. Kuo, and S. H. Chen. 2007. Quantification of meropenem in plasma and cerebrospinal fluid by micellar electrokinetic capillary chromatography and application in bacterial meningitis patients. J. Chromatogr. B 856:294-301.
6. Churchwell, M. I., N. C. Twaddle, L. R. Meeker, and D. R. Doerge. 2005. Improving LC-MS sensitivity through increases in chromatographic performance: comparisons of UPLC-ES/MS/MS to HPLC-ES/MS/MS. J. Chromatogr. B 825:134-143.
7. Denooz, R., and C. Charlier. 2008. Simultaneous determination of five beta-lactam antibiotics (cefepim, ceftazidim, cefuroxim, meropenem and piperacillin) in human plasma by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. B 864:161-167.
8. Farin, D., R. Kitzes-Cohen, G. Piva, and I. Gozlan. 1999. High performance liquid chromatography method for the determination of meropenem in human plasma. Chromatographia 49:253-255.
9. Glew, R. H., and R. A. Pavuk. 1983. Stability of gentamicin, tobramycin, and amikacin in combination with four beta-lactam antibiotics. Antimicrob. Agents Chemother. 24:474-477.
10. Guillarme, D., D. T. Nguyen, S. Rudaz, and J. L. Veuthey. 2007. Recent developments in liquid chromatography - impact on qualitative and quantitative performance. J. Chromatogr. A 1149:20-29.
11. Kraemer, H. J., R. Gehrke, A. Breithaupt, and H. Breithaupt. 1997. Simultaneous quantification of cefotaxime, desacetylcefotaxime, ofloxacine and ciprofloxacine in ocular aqueous humor and in plasma by high-performance liquid chromatography. J. Chromatogr. B 700:147-153.
12. Lindegardh, N., T. Singtoroj, A. Annerberg, N. J. White, and N. P. Day. 2005. Development and validation of a solid-phase extraction-liquid chromatographic method for determination of amoxicillin in plasma. Ther. Drug Monit. 27:503-508.
13. Luksa, J., and A. Marusic. 1995. Rapid high-performance liquid chromatographic determination of vancomycin in human plasma. J. Chromatogr. B 667:277-281.
14. Matuszewski, B. K., M. L. Constanzer, and C. M. Chavez-Eng. 2003. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 75:3019-3030.
15. McCracken, G. H., Jr., N. E. Threlkeld, and M. L. Thomas. 1982. Pharmacokinetics of cefotaxime in newborn infants. Antimicrob. Agents Chemother. 21:683-684.
16. Piva, G., D. Farin, I. Gozlan, and R. Kitzes-Cohen. 2000. HPLC method for determination of cefuroxime in plasma. Chromatographia 51:154-156.
17. Plumb, R., J. Castro-Perez, J. Granger, I. Beattie, K. Joncour, and A. Wright. 2004. Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 18:2331-2337.
18. Pullen, J., L. M. Stolk, F. H. Nieman, P. L. Degraeuwe, F. H. van Tiel, and L. J. Zimmermann. 2006. Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates. Ther. Drug Monit. 28:226-231.
19. Taylor, P. J. 2005. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin. Biochem. 38:328-334.
20. Ward, R. M., W. E. Benitz, D. K. Benjamin, Jr., L. Blackmon, G. P. Giacoia, M. Hudak, T. Lasky, W. Rodriguez, and A. Selen. 2006. Criteria supporting the study of drugs in the newborn. Clin. Ther. 28:1385-1398.